[1] Piantanida E, Ippolito S, Gallo D, et al. The interplay between thyroid and liver: implications for clinical practice[J]. J Endocrinol Invest, 2020, 43(7): 885-899. [2] 裴玲琪, 周怡宏, 林世德. HT合并肝损伤的病因诊断及治疗进展[J]. 海南医学, 2022, 33(7): 922-925. [3] 徐如意, 唐红, 白浪. 新发或未控制HT导致肝损伤的诊断与治疗[J]. 中华肝脏病杂志, 2021, 29(10):926-931. [4] Sheng QJ, Ding Y, Zhang C, et al. Analysis of clinical characteristics of patients with hyperthyroidism combined with liver injury[J]. Zhonghua Gan Zang Bing Za Zhi, 2021, 29(10): 967-971. [5] 中华医学会内分泌学分会. 中国甲状腺疾病诊治指南[J]. 中华内科杂志, 2007, 46(10): 876. [6] 盛秋菊, 丁洋, 张翀, 等. HT合并肝损伤患者的临床特点分析[J]. 中华肝脏病杂志, 2021, 29(10):967-971. [7] Zhao P, Hu Z, Ma W, et al. Quercetin alleviates hyperthyroidism-induced liver damage via Nrf2 Signaling pathway[J]. Biofactors, 2020, 46(4): 608-619. [8] Wafa B, Faten H, Mouna E, et al. Hyperthyroidism and hepatic dysfunction: Report of 17 cases[J]. JGH Open, 2020, 4(5): 876-879. [9] Zhang W, Wang X, Li P, et al. Evaluating hyperthyroidism-induced liver injury based on in situ fluorescence imaging of glutathione and phosphate via nano-mofs Sensor[J]. Anal Chem, 2020, 92(13): 8952-8958. [10] Deshmukh H, Papageorgiou M, Aye M, et al. Hyperthyroidism and bone mineral density: dissecting the causal association with mendelian randomization analysis[J]. Clin Endocrinol (Oxf), 2021, 94(1): 119-127. [11] Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis[J]. Lancet Diabetes Endocrinol, 2023, 11(4): 282-298. [12] Scappaticcio L, Longo M, Maiorino MI, et al. Abnormal liver blood tests in patients with hyperthyroidism: Systematic review and meta-analysis[J]. Thyroid, 2021, 31(6): 884-894. [13] 赵鹏鹏, 王镁. 甲状腺功能亢进合并肝损伤患者70例临床特点及应用保肝药疗效观察[J]. 山西医药杂志, 2022, 51(20): 2311-2315. [14] Naguib R, Fayed A, Elkemary EZ, et al. Evaluation of thyroid function and thyroid autoimmune disease in patients with non-alcoholic fatty liver disease[J]. Clin Exp Hepatol, 2021, 7(4): 422-428. [15] Lian H, Yang HB, Guo XX, et al. Severe hyperthyroidism-heart failure-severe liver injury:report of one case and literature review[J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2019, 41(1): 134-138. [16] Geddes R, Aguiar J. Feline comorbidities: balancing hyperthyroidism and concurrent chronic kidney disease[J]. J Feline Med Surg, 2022, 24(7): 641-650. [17] Bartalena L, Piantanida E, Gallo D, et al. Management of graves′ hyperthyroidism: present and future[J]. Expert Rev Endocrinol Metab, 2022, 17(2): 153-166. [18] Mei X, Zeng J, Dai WX, et al. Prevalence of hyperthyroidism with hypercalcemia in xindu district and the efficacy of vitamin d3 treatment in these patients: a randomized trial[J]. Ann Palliat Med, 2021, 10(9): 9640-9649. |